Cookie Policy

This site uses cookies to store information on your computer.

I accept the terms and conditions
Befehle des Menübands überspringen
Zum Hauptinhalt wechseln

Pall® Filter zur Leukozytenreduktion

LeukoGuard BC2

Pall Leukocyte Reduction Blood Cardioplegia Filter

Features and Benefits
The Pall Leukocyte Reduction Blood Cardioplegia Filter combines leukocyte reduction filtration media with a conventional 40 µm micro-emboli removal screen. The new low volume housing (95 mL) and improved media pleating technique allows easy application in modern blood cardioplegia systems.
● Reduces blood cardioplegia of circulating leukocytes, specifically activated neutrophils, which have been implicated as a major cause of myocardial reperfusion injury. (note: the removal efficiency will depend on total volume of blood cardioplegia delivered and the conditions which the blood cardioplegia is administered (i.e. flow, temperature, haemodilution etc).
● Incorporates a 40 µm screen capable of retaining gaseous and particulate microemboli.
● Designed to handle flow rates up to 350 mL/min, for a 3 litre
throughput, over a wide range of cardioplegia administration practices.

* For clinical data please see clinical update or contact your Pall representative.

Read more

LeukoGuard LG

Pall Leukocyte Reduction Arterial Blood Filter for Extracorporeal Service

Features and Benefits
● Clear, surface modified polycarbonate housing and leukocyte reducing polyester cartridge
● Low, 220 mL priming volume
● Provides a three-stage system for gas separation with automatic venting at flow
rates up to 6 litres a minute
● Includes 40 micron rated polyester screen
● Rapid priming & debubbling
● For arterial and cardiotomy lines

Read more

See Also

Did you not find the product you were looking for ?